ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
jsonm
|
151 |
41K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
41K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
jsonm
|
151 |
41K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
41K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
jsonm
|
41 |
10K |
7 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
jsonm
|
880 |
214K |
3 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
214K
|
3
|
|
ASX - By Stock
|
OIL |
Re:
Convivo Mk 2
|
|
jsonm
|
7 |
9.4K |
2 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
7
|
9.4K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
jsonm
|
953 |
291K |
6 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
953
|
291K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
jsonm
|
953 |
291K |
18 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
953
|
291K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022 - Momma says life is like a box of chocolates
|
|
jsonm
|
222 |
57K |
4 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
222
|
57K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
jsonm
|
1.5K |
506K |
10 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
1.5K
|
506K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
jsonm
|
1.5K |
506K |
16 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
1.5K
|
506K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
jsonm
|
408 |
124K |
4 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
408
|
124K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Norvatis Anniversary
|
|
jsonm
|
58 |
14K |
2 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
58
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
jsonm
|
1.0K |
279K |
1 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
jsonm
|
1.0K |
279K |
17 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
jsonm
|
1.0K |
279K |
27 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
279K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
MSB - A Question of Trust?
|
|
jsonm
|
297 |
71K |
5 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
297
|
71K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
jsonm
|
10K |
3.0M |
2 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
jsonm
|
10K |
3.0M |
5 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
OIL |
Re:
SMSF
|
|
jsonm
|
3 |
1.6K |
4 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
late buy ups
|
|
jsonm
|
9 |
3.0K |
6 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
9
|
3.0K
|
6
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
jsonm
|
533 |
191K |
2 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
533
|
191K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
0 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
126K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
5 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
126K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
0 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
126K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
8 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
126K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
1 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
423
|
126K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
7 |
20/02/21 |
20/02/21 |
ASX - By Stock
|
423
|
126K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
jsonm
|
423 |
126K |
2 |
20/02/21 |
20/02/21 |
ASX - By Stock
|
423
|
126K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Valuation
|
|
jsonm
|
179 |
52K |
7 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
179
|
52K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
jsonm
|
1.1K |
313K |
3 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
3
|
|
ASX - By Stock
|
OIL |
Re:
we're doomed
|
|
jsonm
|
12 |
2.5K |
1 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
12
|
2.5K
|
1
|
|
ASX - By Stock
|
OIL |
Big OIL
|
|
jsonm
|
3 |
1.3K |
12 |
27/09/20 |
27/09/20 |
ASX - By Stock
|
3
|
1.3K
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
jsonm
|
23K |
13M |
8 |
13/06/20 |
13/06/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
jsonm
|
933 |
436K |
1 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
436K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
jsonm
|
933 |
436K |
7 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
436K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
jsonm
|
933 |
436K |
8 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
436K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
jsonm
|
188 |
78K |
2 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
188
|
78K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Half Year Results- Conference Call
|
|
jsonm
|
27 |
171K |
1 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
27
|
171K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Half Year Results- Conference Call
|
|
jsonm
|
27 |
171K |
2 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
27
|
171K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
jsonm
|
23K |
13M |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
17K |
6.7M |
6 |
03/12/19 |
03/12/19 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
PTX Education |
Re:
20 bagger thread
|
|
jsonm
|
318 |
184K |
8 |
28/10/19 |
28/10/19 |
ASX - By Stock
|
318
|
184K
|
8
|
|
ASX - By Stock
|
PTX Education |
Re:
20 bagger thread
|
|
jsonm
|
318 |
184K |
12 |
28/10/19 |
28/10/19 |
ASX - By Stock
|
318
|
184K
|
12
|
|